Home
>
National Drug Code (NDC)
>
Hecoria
Hecoria - 0078-0616-05 - (Tacrolimus)
Drug Information of Hecoria
| Product NDC: | 0078-0616 |
| Proprietary Name: | Hecoria |
| Non Proprietary Name: | Tacrolimus |
| Active Ingredient(s): | .5 mg/1 & nbsp; Tacrolimus |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Hecoria
| Product NDC: | 0078-0616 |
| Labeler Name: | Novartis Pharmaceuticals Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA065461 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20111220 |
Package Information of Hecoria
| Package NDC: | 0078-0616-05 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0078-0616-05) |
NDC Information of Hecoria
| NDC Code | 0078-0616-05 |
| Proprietary Name | Hecoria |
| Package Description | 100 CAPSULE in 1 BOTTLE (0078-0616-05) |
| Product NDC | 0078-0616 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Tacrolimus |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20111220 |
| Marketing Category Name | ANDA |
| Labeler Name | Novartis Pharmaceuticals Corporation |
| Substance Name | TACROLIMUS |
| Strength Number | .5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
